BIOXCEL THERAPEUTICS INC. - COMMON STOCK
0.5848
04-October-24 15:59:45
15 minutes delayed
Stocks
+0.0347
+6.31%
Today's range
0.5500 - 0.5915
ISIN
N/A
Source
NASDAQ
-
15 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
01 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at the 2021 Jefferies London Healthcare Conference
11 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
18 Oct 2021 07:00:00 By Nasdaq GlobeNewswire
-
23 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
-
15 Sep 2021 18:06:00 By Nasdaq GlobeNewswire
-
12 Sep 2021 18:05:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Host Virtual R&D Day on September 23, 2021
09 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Operational Highlights
10 Aug 2021 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference
19 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock
23 Jun 2021 08:28:58 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Proposed Public Offering of Common Stock
22 Jun 2021 16:01:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Host Virtual Commercial Day on June 25, 2021
18 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
26 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
19 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Presentations at the ISBD 2021 Global Annual Conference
11 May 2021 07:00:02 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
10 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
04 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
03 May 2021 07:00:00 By Nasdaq GlobeNewswire